Unknown NA INTERVENTIONAL 2-arm NCT05924230

Dose Responsive Study of Ringer's Lactate Solution in Prevention of Post-induction Hypotension

Dose Responsive Study of Ringer's Lactate Solution in Prevention of Post-induction Hypotension Predicted by Inferior Vena Cava Collapsibility Index in Patients Receiving General Anesthesia

Sponsor: Tata Main Hospital

Conditions Post Induction Hypotension

Interventions RL 10ml/kg RL 15ml/kg

Updated 4 times since 2023 Last updated: Jun 28, 2023 Started: Apr 1, 2023 Primary completion: Jun 30, 2024 Completion: Aug 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Post Induction Hypotension, this trial is ongoing. The trial is conducted by Tata Main Hospital and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Jun 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Jun 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jul 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

Apr 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tata Main Hospital

Data source: Tata Main Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jamshedpur, India